What is Cognitive Research?
Cognitive Research Corporation (CRC) operates as a full-service contract research organization (CRO) dedicated to the Central Nervous System (CNS) product development lifecycle. Serving pharmaceutical, nutraceutical, biotechnology, and medical device companies, CRC is equipped to manage clinical studies across all phases, from I to IV. The organization prides itself on delivering comprehensive, adaptable, quality-focused, and cost-effective services, aiming to act as a seamless extension of its clients' operations to expedite goal achievement. Beyond its core CRO offerings, CRC principals developed CogScreen, a leading computerized psychometric battery recognized for its sensitive measurement of attention, memory, information processing, multi-tasking, and executive functions, positioning the company at the forefront of assessment technology.
How much funding has Cognitive Research raised?
Cognitive Research has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Cognitive Research?
With the recent influx of capital and a history of substantial investment, Cognitive Research Corporation is well-positioned for accelerated growth and market penetration. The company's focus on CNS product development, coupled with its advanced assessment technologies like CogScreen, suggests a strategic direction towards enhancing clinical trial efficiency and data accuracy. Future endeavors will likely involve expanding service offerings, forging new strategic partnerships within the life sciences sector, and potentially leveraging its proprietary assessment tools in broader applications. The substantial backing indicates confidence from investors in CRC's ability to navigate the complex regulatory landscape and deliver value in the development of novel CNS therapies.
See full Cognitive Research company page
